SciLeads at ASGCT 2026
We’re excited to attend the ASGCT 2026 Annual Meeting in Boston. As the premier event for the American Society of Gene & Cell Therapy, this conference is the world’s largest gathering of gene and cell therapy professionals. The event will take place from May 11–15, 2026, at the Thomas M. Menino Convention & Exhibition Center (Boston Convention and Exhibition Center) in Boston, MA. This meeting is an essential destination for those involved in genetic medicine, offering a deep dive into viral vector development, non-viral delivery, and groundbreaking clinical trial results.
About ASGCT 2026
The ASGCT Annual Meeting brings together a diverse global community to explore the latest scientific research and technological advances. Key topics include CRISPR/Cas9 genome editing, CAR-T cell therapies, and RNA-based therapeutics. This event is designed for academic researchers, clinicians, industry partners, and regulatory experts who are focused on moving advanced therapies from the lab to the clinic. Whether you are looking for new laboratory tools or seeking to understand the regulatory landscape for gene-modified products, ASGCT 2026 provides the networking and insights needed to stay ahead in this fast-evolving field.
Key Details for ASGCT 2026
-
Location: Thomas M. Menino Convention & Exhibition Center, 415 Summer Street, Boston, MA 02210, USA
-
Dates: May 11 – May 15, 2026
-
Event Program: ASGCT 2026 Program Overview
Quick Links for ASGCT 2026
-
Registration Details – Options for in-person, virtual, and on-demand access.
-
Exhibitor Information – Resources for booth bookings and visibility opportunities.
-
Abstract Submission Site – The portal for submitting original research and late-breaking data.
-
Housing and Travel – Information on official hotel blocks in the Boston Seaport district.
-
About ASGCT – Learn more about the society’s mission and professional membership.
Deadlines for ASGCT 2026
-
November 01, 2025: Abstract submissions open.
-
December 01, 2025: Registration for the Annual Meeting opens.
-
January 31, 2026: Regular abstract submission deadline.
-
February 28, 2026: Early-bird registration rates end.
-
March 15, 2026: Notification of abstract acceptance.
-
April 01, 2026: Late-breaking abstract submission deadline.
-
May 11, 2026: ASGCT 2026 Annual Meeting begins in Boston.
Key Topics and Speakers for ASGCT 2026
-
Gene Augmentation and Editing: Advances in CRISPR, base editing, and prime editing technologies.
-
Cell-Based Therapies: Developments in CAR-T, CAR-NK, and engineered TCR therapies.
-
Vector Development and Manufacturing: Scaling AAV, lentiviral, and non-viral delivery systems.
-
Clinical Trials and Regulatory Affairs: Insights from FDA and EMA on therapy approvals and safety.
-
RNA-Based Therapeutics: New Frontiers in mRNA, siRNA, and antisense oligonucleotides.
-
Ethical, Legal, and Social Issues: Addressing patient access and the bioethics of genomic medicine.
Who attends ASGCT Annual Meeting
-
Academic Researchers and Principal Investigators
-
Clinicians and Medical Geneticists
-
Biotech and Pharmaceutical Industry Executives
-
Regulatory Affairs Specialists (e.g., FDA, EMA)
-
Laboratory Managers and Technicians
-
Bioinformaticians and Data Scientists
-
Patient Advocates and Policy Makers
-
PhD Students and Postdoctoral Fellows